Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line < em > Helicobacter Pylori < /em > Eradication Therapy Administered with Bismuth
CONCLUSION: In eradication-naive patients, eradication success rates for 7-day first-line triple therapy regimen exceeded 82% with bismuth administration. In clarithromycin-resistant patients, neither tegoprazan 50 mg nor lansoprazole 30 mg achieved acceptable eradication rates when administered twice daily for 7 days.PMID:34296548 | PMC:PMC8298865 | DOI:10.3349/ymj.2021.62.8.708 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - July 23, 2021 Category: Universities & Medical Training Authors: Ji Yeon Kim Sun Young Lee Hyobin Kim Jeong Hwan Kim In Kyung Sung Hyung Seok Park Source Type: research
Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line < em > Helicobacter Pylori < /em > Eradication Therapy Administered with Bismuth
CONCLUSION: In eradication-naive patients, eradication success rates for 7-day first-line triple therapy regimen exceeded 82% with bismuth administration. In clarithromycin-resistant patients, neither tegoprazan 50 mg nor lansoprazole 30 mg achieved acceptable eradication rates when administered twice daily for 7 days.PMID:34296548 | PMC:PMC8298865 | DOI:10.3349/ymj.2021.62.8.708 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - July 23, 2021 Category: Universities & Medical Training Authors: Ji Yeon Kim Sun Young Lee Hyobin Kim Jeong Hwan Kim In Kyung Sung Hyung Seok Park Source Type: research
Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line < em > Helicobacter Pylori < /em > Eradication Therapy Administered with Bismuth
CONCLUSION: In eradication-naive patients, eradication success rates for 7-day first-line triple therapy regimen exceeded 82% with bismuth administration. In clarithromycin-resistant patients, neither tegoprazan 50 mg nor lansoprazole 30 mg achieved acceptable eradication rates when administered twice daily for 7 days.PMID:34296548 | PMC:PMC8298865 | DOI:10.3349/ymj.2021.62.8.708 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - July 23, 2021 Category: Universities & Medical Training Authors: Ji Yeon Kim Sun Young Lee Hyobin Kim Jeong Hwan Kim In Kyung Sung Hyung Seok Park Source Type: research
Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line < em > Helicobacter Pylori < /em > Eradication Therapy Administered with Bismuth
CONCLUSION: In eradication-naive patients, eradication success rates for 7-day first-line triple therapy regimen exceeded 82% with bismuth administration. In clarithromycin-resistant patients, neither tegoprazan 50 mg nor lansoprazole 30 mg achieved acceptable eradication rates when administered twice daily for 7 days.PMID:34296548 | PMC:PMC8298865 | DOI:10.3349/ymj.2021.62.8.708 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - July 23, 2021 Category: Universities & Medical Training Authors: Ji Yeon Kim Sun Young Lee Hyobin Kim Jeong Hwan Kim In Kyung Sung Hyung Seok Park Source Type: research
Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line < em > Helicobacter Pylori < /em > Eradication Therapy Administered with Bismuth
CONCLUSION: In eradication-naive patients, eradication success rates for 7-day first-line triple therapy regimen exceeded 82% with bismuth administration. In clarithromycin-resistant patients, neither tegoprazan 50 mg nor lansoprazole 30 mg achieved acceptable eradication rates when administered twice daily for 7 days.PMID:34296548 | PMC:PMC8298865 | DOI:10.3349/ymj.2021.62.8.708 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - July 23, 2021 Category: Universities & Medical Training Authors: Ji Yeon Kim Sun Young Lee Hyobin Kim Jeong Hwan Kim In Kyung Sung Hyung Seok Park Source Type: research
Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line < em > Helicobacter Pylori < /em > Eradication Therapy Administered with Bismuth
CONCLUSION: In eradication-naive patients, eradication success rates for 7-day first-line triple therapy regimen exceeded 82% with bismuth administration. In clarithromycin-resistant patients, neither tegoprazan 50 mg nor lansoprazole 30 mg achieved acceptable eradication rates when administered twice daily for 7 days.PMID:34296548 | PMC:PMC8298865 | DOI:10.3349/ymj.2021.62.8.708 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - July 23, 2021 Category: Universities & Medical Training Authors: Ji Yeon Kim Sun Young Lee Hyobin Kim Jeong Hwan Kim In Kyung Sung Hyung Seok Park Source Type: research
Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line < em > Helicobacter Pylori < /em > Eradication Therapy Administered with Bismuth
CONCLUSION: In eradication-naive patients, eradication success rates for 7-day first-line triple therapy regimen exceeded 82% with bismuth administration. In clarithromycin-resistant patients, neither tegoprazan 50 mg nor lansoprazole 30 mg achieved acceptable eradication rates when administered twice daily for 7 days.PMID:34296548 | PMC:PMC8298865 | DOI:10.3349/ymj.2021.62.8.708 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - July 23, 2021 Category: Universities & Medical Training Authors: Ji Yeon Kim Sun Young Lee Hyobin Kim Jeong Hwan Kim In Kyung Sung Hyung Seok Park Source Type: research
Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line < em > Helicobacter Pylori < /em > Eradication Therapy Administered with Bismuth
CONCLUSION: In eradication-naive patients, eradication success rates for 7-day first-line triple therapy regimen exceeded 82% with bismuth administration. In clarithromycin-resistant patients, neither tegoprazan 50 mg nor lansoprazole 30 mg achieved acceptable eradication rates when administered twice daily for 7 days.PMID:34296548 | PMC:PMC8298865 | DOI:10.3349/ymj.2021.62.8.708 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - July 23, 2021 Category: Universities & Medical Training Authors: Ji Yeon Kim Sun Young Lee Hyobin Kim Jeong Hwan Kim In Kyung Sung Hyung Seok Park Source Type: research
D-Galacturonic acid reduction by S. cerevisiae for L-galactonate production from extracted sugar beet press pulp hydrolysate
Appl Microbiol Biotechnol. 2021 Jul 16. doi: 10.1007/s00253-021-11433-5. Online ahead of print.ABSTRACTPectin-rich residues are considered as promising feedstocks for sustainable production of platform chemicals. Enzymatic hydrolysis of extracted sugar beet press pulp (SBPP) releases the main constituent of pectin, D-galacturonic acid (D-GalA). Using engineered Saccharomyces cerevisiae, D-GalA is then reduced to L-galactonate (L-GalOA) with sorbitol as co-substrate. The current work addresses the combination of enzymatic hydrolysis of pectin in SBPP with a consecutive optimized biotransformation of the released D-GalA to L...
Source: Applied Microbiology and Biotechnology - July 16, 2021 Category: Microbiology Authors: J Wagner D Sch äfer N von den Eichen C Haimerl S Harth M Oreb J P Benz D Weuster-Botz Source Type: research
D-Galacturonic acid reduction by S. cerevisiae for L-galactonate production from extracted sugar beet press pulp hydrolysate
Appl Microbiol Biotechnol. 2021 Jul 16. doi: 10.1007/s00253-021-11433-5. Online ahead of print.ABSTRACTPectin-rich residues are considered as promising feedstocks for sustainable production of platform chemicals. Enzymatic hydrolysis of extracted sugar beet press pulp (SBPP) releases the main constituent of pectin, D-galacturonic acid (D-GalA). Using engineered Saccharomyces cerevisiae, D-GalA is then reduced to L-galactonate (L-GalOA) with sorbitol as co-substrate. The current work addresses the combination of enzymatic hydrolysis of pectin in SBPP with a consecutive optimized biotransformation of the released D-GalA to L...
Source: Applied Microbiology and Biotechnology - July 16, 2021 Category: Microbiology Authors: J Wagner D Sch äfer N von den Eichen C Haimerl S Harth M Oreb J P Benz D Weuster-Botz Source Type: research
Gitelman Syndrome in Pregnancy: A Clinical Challenge
CONCLUSION: Increased need for potassium and magnesium supplementation should be the critical considerations when managing pregnant patients with GS.PMID:34126642 | DOI:10.1055/a-1498-2940 (Source: Zeitschrift fur Geburtshilfe und Neonatologie)
Source: Zeitschrift fur Geburtshilfe und Neonatologie - June 14, 2021 Category: Perinatology & Neonatology Authors: Seval Yilmaz Ergani Gokcen Orgul Harun Egemen Tolunay Mustafa Arici Aykan Yucel Dilek Uygur Source Type: research
Gitelman Syndrome in Pregnancy: A Clinical Challenge
CONCLUSION: Increased need for potassium and magnesium supplementation should be the critical considerations when managing pregnant patients with GS.PMID:34126642 | DOI:10.1055/a-1498-2940 (Source: Zeitschrift fur Geburtshilfe und Neonatologie)
Source: Zeitschrift fur Geburtshilfe und Neonatologie - June 14, 2021 Category: Perinatology & Neonatology Authors: Seval Yilmaz Ergani Gokcen Orgul Harun Egemen Tolunay Mustafa Arici Aykan Yucel Dilek Uygur Source Type: research
Gitelman Syndrome in Pregnancy: A Clinical Challenge
CONCLUSION: Increased need for potassium and magnesium supplementation should be the critical considerations when managing pregnant patients with GS.PMID:34126642 | DOI:10.1055/a-1498-2940 (Source: Zeitschrift fur Geburtshilfe und Neonatologie)
Source: Zeitschrift fur Geburtshilfe und Neonatologie - June 14, 2021 Category: Perinatology & Neonatology Authors: Seval Yilmaz Ergani Gokcen Orgul Harun Egemen Tolunay Mustafa Arici Aykan Yucel Dilek Uygur Source Type: research
Gitelman Syndrome in Pregnancy: A Clinical Challenge
CONCLUSION: Increased need for potassium and magnesium supplementation should be the critical considerations when managing pregnant patients with GS.PMID:34126642 | DOI:10.1055/a-1498-2940 (Source: Zeitschrift fur Geburtshilfe und Neonatologie)
Source: Zeitschrift fur Geburtshilfe und Neonatologie - June 14, 2021 Category: Perinatology & Neonatology Authors: Seval Yilmaz Ergani Gokcen Orgul Harun Egemen Tolunay Mustafa Arici Aykan Yucel Dilek Uygur Source Type: research
Gitelman Syndrome in Pregnancy: A Clinical Challenge
CONCLUSION: Increased need for potassium and magnesium supplementation should be the critical considerations when managing pregnant patients with GS.PMID:34126642 | DOI:10.1055/a-1498-2940 (Source: Zeitschrift fur Geburtshilfe und Neonatologie)
Source: Zeitschrift fur Geburtshilfe und Neonatologie - June 14, 2021 Category: Perinatology & Neonatology Authors: Seval Yilmaz Ergani Gokcen Orgul Harun Egemen Tolunay Mustafa Arici Aykan Yucel Dilek Uygur Source Type: research
